AXIOS January 9, 2020
Returns on 2019 health care IPOs
Each circle is a company, sized by its year-end stock price
Two-thirds of the 68 health care companies that went public in 2019 traded above their IPO price by the end of year — many of which provided huge initial returns to owners and outside investors.
The big picture: The vast majority of health care companies that go public are biotechnology firms. Several of those biotechs in the 2019 class benefited from some promising, but extremely early, clinical trial data.
By the numbers: If you bought an equal amount of shares of every health care company that went public last year and then sold before the calendar flipped, you would...
Today's Sponsors
Today's Sponsor